{
    "Trade/Device Name(s)": [
        "PATHFAST\u00ae cTnI-II test",
        "PATHFAST\u00ae cTnI Calibrators",
        "PATHFAST\u00ae Sample Diluent 2"
    ],
    "Submitter Information": "LSI Medience Corporation",
    "510(k) Number": "K100130",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033487"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI",
        "JIT"
    ],
    "Summary Letter Date": "May 5, 2011",
    "Summary Letter Received Date": "May 11, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine Phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac Troponin I"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "PATHFAST instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for PATHFAST cTnI-II test, calibrators, and sample diluent for quantitative cardiac troponin I measurement in whole blood or plasma using chemiluminescent immunoassay on the PATHFAST instrument",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative measurement of cardiac Troponin I in heparinized or EDTA whole blood and plasma as an aid in diagnosis of acute myocardial infarction, for use in clinical laboratory or point of care settings",
    "fda_folder": "Clinical Chemistry"
}